TNF and colorectal carcinoma: Therapeutic interventions involving anti-TNFα antibodies or TNF receptor fusion molecules have demonstrated efficacy in genetic models of liver cancer and CRC, although the precise mechanism of action of these therapies remains to be elucidated (Pikarsky et al., 2004; Rao et al., 2006).